Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Venous Thrombosis × Bevacizumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 74 Ovarian Neoplasms 28 Carcinoma, Non-Small-Cell Lung 24 Breast Neoplasms 24 Colonic Neoplasms 20 Rectal Neoplasms 18 Neoplasms 16 Fallopian Tube Neoplasms 16 Neoplasm Metastasis 11 Carcinoma, Hepatocellular 11 Glioblastoma 10 Carcinoma, Renal Cell 7 Brain Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Lung Neoplasms 6 Uterine Cervical Neoplasms 5 Intestinal Neoplasms 5 Gastrointestinal Neoplasms 5 Digestive System Neoplasms 5 Brenner Tumor 5 Recurrence 4 Glioma 4 Rectal Diseases 3 Peritoneal Neoplasms 3 Liver Neoplasms 3 Intestinal Diseases 3 Gastrointestinal Diseases 3 Digestive System Diseases 3 Colonic Diseases 3 Carcinoma, Ovarian Epithelial 3

Interventions

Dalteparin 5 apixaban 4 edoxaban 2 bemiparin 2 abelacimab 2 Tinzaparin 2 Nadroparin 2 MAA868 2 Heparin, Low-Molecular-Weight 2 Enoxaparin 2 reviparin 1 certoparin 1 atezolizumab 1 acarboxyprothrombin 1 Warfarin 1 Rivaroxaban 1 Phenprocoumon 1 Intermittent Pneumatic Compression Devices 1 Fondaparinux 1 Dabigatran 1 Bevacizumab 1 Acenocoumarol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04649489 2026-01-15

TALENTOP

Fudan University

Phase 3 Active not recruiting

Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡